Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Other 1

Conditions

Radiation Fibrosis Syndrome 1Precancerous Conditions 1Pancreatic Neoplasms 1Lung Neoplasms 1Dyspnea 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Radiosurgery 27Blood Specimen Collection 20Drug Therapy 18Radiotherapy 14Early Intervention, Educational 14Magnetic Resonance Spectroscopy 13Standard of Care 12Pemetrexed 12Carboplatin 12Exercise 11Practice Guidelines as Topic 9X-Rays 8Psychiatric Rehabilitation 8Methods 8Immunotherapy 8Therapeutics 7Surgical Procedures, Operative 7Paclitaxel 7Fluorodeoxyglucose F18 7Surveys and Questionnaires 6Counseling 6Cisplatin 6Biopsy 6Anterior Temporal Lobectomy 6Thoracic Surgery, Video-Assisted 5Liquid Biopsy 5Gemcitabine 5Erlotinib Hydrochloride 5Docetaxel 5Bevacizumab 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Carcinoma, Non-Small-Cell Lung × Losartan × Clear all
NCT00880386 2017-05-02

Losartan in Treating Pulmonary Fibrosis in Patients With Stage I, II, or III Non-Small Cell Lung Cancer

University of South Florida

Phase NA Withdrawn
OtherThoracic

Radiation Fibrosis Syndrome, Carcinoma, Non-Small-Cell Lung, Dyspnea, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡